Login

Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Current assets
Cash
Prepaid expenses
Total Current Assets
Deferred offering costs
Marketable securities held in Trust Account
Marketable securities held in Trust Account
TOTAL ASSETS
Current liabilities
Accounts payable and accrued expenses
Accrued offering costs
Income taxes payable
Redemption payable
Total Current Liabilities
Warrant liabilities
Deferred underwriting fee payable
Warrant liabilities
Deferred underwriting fee payable
TOTAL LIABILITIES
Class A common stock subject to possible redemption 2,022,043 shares outstanding at redemption value of $10.20 and $10.07 as of June 30, 2023 and December 31, 2022, respectively
Stockholders’ Deficit
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding
Common stock value
Class A Common Stock
Class B Common Stock
Total common stock value
Class B common stock, $0.0001 par value; 25,000,000 shares authorized; 360,000 shares issued and outstanding, as of March 31, 2023 and December 31, 2022, respectively
Additional paid-in capital
Accumulated deficit
Class A Common Stock
Class B Common Stock
Total Stockholders’ Deficit
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support